ATE290878T1 - Inhibierung von invasiver remodulierung - Google Patents

Inhibierung von invasiver remodulierung

Info

Publication number
ATE290878T1
ATE290878T1 AT97946746T AT97946746T ATE290878T1 AT E290878 T1 ATE290878 T1 AT E290878T1 AT 97946746 T AT97946746 T AT 97946746T AT 97946746 T AT97946746 T AT 97946746T AT E290878 T1 ATE290878 T1 AT E290878T1
Authority
AT
Austria
Prior art keywords
inhibitor
invasive
novel
inhibition
plasmin
Prior art date
Application number
AT97946746T
Other languages
English (en)
Inventor
Leif Roege Lund
Keld Danoe
Ross Stephens
Nils Bruenner
Helene Solberg
Claus Holst-Hansen
John Roemer Nielsen
Original Assignee
Fonden Til Fremme Af Eksperime
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fonden Til Fremme Af Eksperime filed Critical Fonden Til Fremme Af Eksperime
Application granted granted Critical
Publication of ATE290878T1 publication Critical patent/ATE290878T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT97946746T 1996-12-06 1997-12-08 Inhibierung von invasiver remodulierung ATE290878T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK140296 1996-12-06
PCT/DK1997/000555 WO1998024474A1 (en) 1996-12-06 1997-12-08 Inhibition of invasive remodelling

Publications (1)

Publication Number Publication Date
ATE290878T1 true ATE290878T1 (de) 2005-04-15

Family

ID=8104458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97946746T ATE290878T1 (de) 1996-12-06 1997-12-08 Inhibierung von invasiver remodulierung

Country Status (6)

Country Link
EP (1) EP0942746B1 (de)
AT (1) ATE290878T1 (de)
AU (1) AU5187698A (de)
DE (1) DE69732784T2 (de)
ES (1) ES2239787T3 (de)
WO (1) WO1998024474A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
AU2002358921A1 (en) * 2001-07-10 2003-04-28 Omnio Ab Novel drug targets for arthritis
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US20030195164A1 (en) * 2002-04-16 2003-10-16 Veli-Matti Kahari Novel ribozyme and its use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2188322A (en) * 1986-03-26 1987-09-30 Bayer Ag Aprotinin and analogues thereof produced by a recombinant host
DE4115453A1 (de) * 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors

Also Published As

Publication number Publication date
EP0942746A1 (de) 1999-09-22
ES2239787T3 (es) 2005-10-01
AU5187698A (en) 1998-06-29
WO1998024474A1 (en) 1998-06-11
EP0942746B1 (de) 2005-03-16
DE69732784D1 (de) 2005-04-21
DE69732784T2 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
WO2001062280A3 (en) Lipase-containing composition and methods of use thereof
ATE357272T1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
MY121222A (en) Prodrugs of thrombin inhibitors
BG103392A (en) Serine protease inhibitors, in particular of hepatitis with virus ns3 protease
NZ335981A (en) Ketobenzamides as calpain inhibitors
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
DK39093D0 (da) Enzym
DK0850307T3 (da) Alkalifile og termofile mikroorganismer og enzymer, der opnås derfra
AU8112101A (en) Non-imidazole aryloxypiperidines
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
HK1016495A1 (en) Phosphorous-containing cysteine and serine protease inhibitors
HK1029936A1 (en) Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors
HK1025511A1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
EP0930067A3 (de) Mmp inhibitoren zur behandlung von okularer angiogenesis
ATE277943T1 (de) Trypsininhibitoren
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DE69732784D1 (de) Inhibierung von invasiver remodulierung
IL152906A0 (en) Method for selecting enzyme inhibitors
ZA9711468B (en) New use of comt inhibitors
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
MXPA03001986A (es) Composiciones antitromboticas.
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
PT1144348E (pt) Inibidores de lta, hidrolase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties